EMERGENT BIOSOLUTIONS INC. for EMERGENT BIOSOLUTIONS INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Disaster Planning/Emergencies DIS
-FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -NDAA - provisions related to biological and chemical defense -Department of Defense appropriations for Medical Countermeasures -FDA regulatory issues -Issues related to Priority Review Voucher programs -Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT BARBOSA | — |
| CHRIS FRECH | — |
| KATHERINE GETTY New | — |
| JILL HAMAKER | — |
Budget/Appropriations BUD
-FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -Re-authorization of the Pandemic and All-Hazards Preparedness Act -NDAA - provisions related to biological and chemical defense -Department of Defense appropriations for Medical Countermeasures FDA regulatory issues -Issues related to Priority Review Voucher programs -Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT BARBOSA | — |
| CHRIS FRECH | — |
| KATHERINE GETTY | — |
Homeland Security HOM
-FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -NDAA - provisions related to biological and chemical defense -Department of Defense appropriations for Medical Countermeasures -FDA regulatory issues -Issues related to Priority Review Voucher programs -Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT BARBOSA | — |
| CHRIS FRECH | — |
| KATHERINE GETTY | — |
| JILL HAMAKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.